Abu Dhabi, 10 December, 2017: National Reference Laboratory (NRL), part of Mubadala’s network of world-class healthcare providers, recently organized an Inspector Training Program in Abu Dhabi in collaboration with the College of American Pathologists (CAP). The faculty included members of the CAP leadership from the USA, as well as global and local experts who are highly experienced with the quality accreditation process. Approximately 250 professionals attended the program designed to raise awareness of the CAP checklists and their impact on quality patient care.
Though the laboratory is rarely visible to the patient, around 70 percent of medical decisions are influenced by laboratory tests. Laboratory-specific quality accreditations are the integral element for securing quality practices, which ensure improved patients outcomes by providing high quality of services and reducing the unnecessary costs in the industry.
Commenting on the recent Inspector’s Training Program, Abdul Hamid Oubeisi, CEO of NRL, said: “We are delighted to have had the opportunity to co-organize this training with the CAP, during which we witnessed great enthusiasm and energy from the participants during this event. The program, which saw the participation of leading experts from the CAP, our partner LabCorp, and NRL, provided a platform to share our knowledge and experience with the regional medical community, aligned with our mission to improve the standards of laboratory excellence and patient care.”
“By co-organizing a CAP inspectors training program, NRL is supporting CAP in raising awareness of CAP checklists and standards and their impact on quality patient care. We were honored to see the impressive attendance and the interest of the participants to learn about the standards. We are looking forward to organizing additional training programs in the Middle East region in partnership with NRL” said Dr. Bharati Jhavieri, Chair of the Council on Accreditation of the CAP.
Dr. Rania Seliem, Laboratory Director of DHA’s Rashid Hospital, and an attendee of the Inspector’s Training Program, stated: “My team and I found this training to be a valuable experience, which provided participants with an insightful perspective of the CAP standards. Through interactive sessions and engaging with global and local experts, we were able to significantly improve our understanding of the standards requirements and the methods of implementing them through our work.”
As the largest CAP-accredited laboratory network in the Middle East, NRL’s scientific expertise, technological capabilities and quality infrastructure has allowed it to become a leader in laboratory medicine. With a mission of better serving patients across the region, NRL has been committed to securing accreditation and adopting international standards of quality and operations.
CAP’s Laboratory Accreditation Program is recognized as a leading accreditation program given the diversity of laboratories it inspects, and its peer-based inspection approach which provides regulatory requirements and educational mentoring from respected pathologists and laboratory professionals. The CAP continues to increase its international purview and NRL has partnered with them in the UAE in this endeavor.
About National Reference Laboratory
National Reference Laboratory is a Mubadala Company created in partnership with and managed by Laboratory Corporation of America® Holdings (LabCorp®), a world leading life sciences company providing comprehensive clinical laboratory services.
National Reference Laboratory’s vision is to increase the spectrum, coverage and overall efficiency of laboratory testing, to implement international best practice reference laboratory processes and to set the benchmark for quality standards in the region. Together with the significant resources of LabCorp, National Reference Laboratory offers a comprehensive menu of more than 4,700 tests, providing a complete solution for all clinical testing needs in an efficient and high-quality environment that reduces both turnaround time and logistics-related costs, compared with other laboratories. The diverse and growing network of NRL currently includes ten owned and managed laboratories across the UAE. For more information, please visit www.nrl.ae.
Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With net revenue in excess of US$9.4 billion in 2016 and more than 50,000 employees in over 60 countries, LabCorp offers innovative solutions to healthcare stakeholders. LabCorp clients include physicians, patients and consumers, biopharmaceutical companies, government agencies, managed care organizations, hospitals, and clinical labs. To learn more about Covance Drug Development, visit www.covance.com. To learn more about LabCorp and LabCorp Diagnostics, visit www.labcorp.com.